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ABSTRACT

This study examined the in vitro production of
corticosteroid-binding globulin (CBG) by liver collected

from pigs at various ages following birth, the effects of
various hormone treatments on the in vitro hepatic release

of CBG, and the relationship between the hormone effects and

postnatal development. Liver was collected from pigs (n=20)
immediately following euthanasia on 3, 10, 20, 30 or 40 days
of age. Liver slices (200 mg) were incubated for 12 and 24

hours with either cortisol (10"'^ M), estradiol (10~® M),

progesterone (lO""^ M), or thyroxine (10"'^ M) prepared in
0.5% ethanol. A single blood sample was collected upon
euthanasia for determination of plasma CBG levels. The

amount of CBG released per unit weight of liver slices and
in circulation was measured using an

enzyme-linked

immunosorbent assay (ELISA) procedure. The percentage of

cell's dying and the amount of total protein released were
measured to compare with CBG concentration. Cell death was

higher (P<0.05) on days 3, 10, and 20 than on days 30 and
40. Addition of 0.5% ethanol to the media did not affect the

release of total protein or CBG. The release of total

protein did not change (P>0.10) with age. Plasma CBG levels
increased (P<0.05) on day 30 and CBG levels measured in
media from liver slices decreased (P<0.01) on day 20.

Hormone treatment had no apparent effect on the release of
iv

CBG by the cultured liver. Consequently, the release of CBG
per unit weight of liver decreased (P<0.01) on day 20. CBG
release from hepatic tissue may be regulated in a different
manner from that of other proteins. The absence of a hormone
treatment effect on the release of CBG from liver slices may

indicate that regulation of CBG release from the liver may
be primarily related to age.
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CHAPTER I

INTRODUCTION

During the period from birth to weaning the young pig
encounters various environmental and management-related

stressors (Curtis, 1974; England, 1974; Mersmann, 1974). The

adrenal glucocorticoid, cortisol, plays an important role in
the pig's ability to adjust

to these stressors as well as

in the maturation process (Baxter and Rousseau, 1979).
Cortisol exists in plasma in either the unbound or proteinbound forms. The major cortisol binding proteins in plasma
are corticosteroid-binding globulin(CBG) and albumin
(Ballard, 1979).

CBG binds cortisol with remarkably high

affinity and specificity (Slaunwhite, Jr. and Sandberg,
1959). As a result, CBG not only transports cortisol but
also modulates the bioavailability of cortisol to target
cells (Siiteri et al., 1982).

The plasma levels of CBG are determined by its hepatic
synthesis, metabolism, and transfer to extravascular spaces.

The amount of CBG in plasma varies with age (Henning, 1978;
Dalle et al., 1980; Kattesh and Robert, 1993), gender (Dalle

et al., 1980; Mataradze et al., 1992), and physiological
conditions including pregnancy ( Rosenthal et al., 1969;
Cohen et al., 1990; Martin and Silberzahn, 1990; Scott et

al., 1990) and inflammation (Hammond et al., 1990). CBG is
1

mainly produced by the hepatocyte (Scrocchi et al., 1993)
and its production is regulated by various hormones (Feldman
et al., 1979; Elfahime et al., 1992; Smith and Hammond,
1992). CBG production in response to these hormones may vary

with age (D'agostino and Henning, 1981, 1982).
The objective of this study was to investigate the

relationship between age and hormonal regulation of in vitro

hepatic secretion of corticosteroid-binding globulin in the
young pig.

CHAPTER II

REVIEW OF LITERATURE

Environmental influence on the development of young pig

During the period from birth to weaning the young pig
must cope and respond to a changing environment. Before
birth the piglet is provided predigested nutrients, oxygen,
a warm environment and antibodies by the sow. However,

following birth the piglet must perform digestion,
respiration, thermoregulation and antibody production by
itself (Curtis, 1974; Wilson, 1974).

It is not uncommon for a swine producer to experience

a 20 to 30% pig death loss between birth and weaning. This
poor survival rate may be attributed to several aspects
related to physiological immaturity such as low levels of

phosphorylase, defective gluconeogenic capacity, a deficient
hepatic mitochondrial number, low body fat stores, and
defects in amino acid metabolism (Mersmann, 1974).

Environmental stressors encountered by the piglet following

birth (i.e. temperature change) make it more difficult for
the animal to maintain homeostasis (Curtis, 1974).

Roles of Cortisol

Hormones serve as regulators of various physiological
functions in maintaining homeostasis and participating in
3

the maturation process. It is known that adrenal

glucocorticoids, primarily cortisol in the pig, play an
important role in adaptation to environmental changes
(Baxter and Rousseau, 1979), inflammation (Fauci, 1979) and

the initiation of parturition (First and Bosc, 1979).
Cortisol production results from activation of the

hypothalamic-pituitary-adrenal axis (HPA). The hypothalamus

produces corticotrophin releasing hormone (CRH) which
stimulates the production of adrenocorticotropic hormone

(ACTH) by the anterior pituitary gland. The adrenal cortex
depends on ACTH for the production of cortisol (Baxter and
Rousseau, 1979).

The effects of cortisol on glucose and protein

metabolism are grossly anabolic in the liver and catabolic
and anti-anabolic in certain other tissues. Cortisol

increases glucose production in the liver through induction
of

gluconeogenic enzymes and increased availability of

substrates. Cortisol induces the breakdown of both protein

and nucleic acids and decreases protein synthesis in muscle

(Exton, 1979). In adipose tissue, cortisol stimulates

lipolysis and promotes the lipolytic effect of epinephrine
and increases the production of lactate (Baxter and

Rousseau, 1979). Thus, cortisol acts to mobilize energy

sources during prolonged inaccessibility to an immediate

energy substrate, especially glucose (Baxter and Rousseau,
1979).
4

Cortisol is important for the maintenance of normal
blood pressure through direct influence on cardiac
contractility, vascular reactivity and vascular tone.

Cortisol may directly influence the glomerular filtration
rate and therefore increase the clearance of water (Baxter

and Rousseau, 1979).

Cortisol can directly act on the central nervous

system. Patients with Cushing's syndrome resulting from
hypersecretion of cortisol by adrenal cortex may appear

euphoric with an increase in appetite. Similarly, Addison's
syndrome with cortisol deficiency by gradual destrution of
adrenal cortex due to an auto immune process or tuberculosis
is associated with depression and a general lack of feeling
well (McEwen, 1979).

Cortisol may profoundly influence the course of

infections and the inflammatory and immunologic responses.
Cortisol can suppress virtually every phase of the
immunologic and inflammatory response. The effects are very
selective and there are marked species differences in
sensitivity (Fauci, 1979).

Distribution of cortisol in circulation

Cortisol exists in plasma in both unbound and proteinbound forms (Ballard, 1979). It is generally believed that

the protein-bound form is biologically inactive and only the
unbound steroid can gain access to target tissues and
5

initiate actions. The major cortisol binding proteins in

plasma are corticosteroid-binding globulin (CBG; transcortin
in humans) and albumin. Although CBG is present in plasma at
low concentrations, CBG is a major binder of cortisol due to

its high affinity for this particular ligand. In contrast,
albumin is present at a high concentration and has a

much

lower affinity (Siiteri et al., 1982). The normal
concentration of CBG in humans is 0.71 uM with an
'1

association constant for cortisol at 3.0 x 10

L/mol. In

contrast, albumin plasma levels are 550 uM with an

association constant for cortisol at 0.5 x 10^ L/mol. In
spite of the large concentration difference between CBG and
albumin in plasma, the percentage of cortisol bound to CBG
is significantly higher than that bound to albumin (78% vs
15%; Ballard, 1979).

Gayrard et al.(1996) calculated unbound, CBG-bound, and
albumin-bound cortisol fractions from the CBG-binding

parameters and measured plasma cortisol levels in several

species to evaluate the potential availability of cortisol
to target tissues. Plasma cortisol concentrations varied
from 0.02 to 0.05 uM (ewe, dog, cow), 0.1 to 0.6 uM (horse,

human, cynomolgus monkey), and 1.6 uM (squirrel monkey). The

CBG maximal capacity was 3 (1.7 to 5.2) times more than the

plasma cortisol levels, with the cow, dog and ewe exhibiting
the lowest and the cynomologus monkey exhibiting the highest

capacity. The distribution of unbound(6 to 14%), CBG-bound
6

(67 to 87 %) and albumin-bound (7 to 19%) fractions of
cortisol were similar between species.

This pattern of cortisol distribution may vary due to

age. In the newborn guinea-pig the unbound, CBG-bound and
albumin-bound fractions were 20, 62 and 18 %, respectively

(Dalle et al., 1980). By day 20 of age the unbound fraction
was 6 %, the CBG-bound fraction was 88 % and the albuminbound fraction was 6%. Kattesh et al.(1990) reported that in

the pig unbound, CBG-bound, and albumin-bound cortisol
fractions were 30%, 40%, and 30% at birth, respectively and
15%, 54%, and 31% on day 42, respectively. Unbound cortisol

appears to be high at birth and decreases with age. This
change in distribution of cortisol may have an important
role in the maturation and adaptation of the animal during
early postnatal development.

CBG Structure

The CBG molecule is associated with the alpha-globulin
area in the electrophoretic separation of human plasma

proteins (Slaunwhite and Sandberg, 1959) and is
characterized as a 50-60 kDa monomeric glycoprotein with a

single steroid binding site that interacts preferentially

with biologically active glucocorticoids (Hammond et al.,
1991). Human CBG is composed of 383 amino acids, and has a

polypeptide molecular weight of 42,646 (Hammond et al.,
1987). There are two cysteine residues and six consensus
7

sites for N-glycosylation.

A number of CBG complementary

DNAs (cDNA) from human liver and lung libraries have been
isolated by production of specific antisera against human
CBG and used to isolate cDNAs for CBG from other species

(Hammond et al., 1987). Phylogenetic comparisons of their

primary structures reveal conserved domains that may be
structurally and functionally important (Hammond, 1990).
Smith and Hammond (1989) isolated CBG cDNA from a

lamda-gt liver cDNA library and determined the primary
structure of rat CBG. The protein contained 374 amino acids
(Mr = 42,196) and six consensus sites for N-glycosylation.

There was a 60% identity over 383 residues to that of human
CBG. Furthermore, the single cysteine in rat CBG
corresponded to one of two cysteines in human CBG. Northern
analysis revealed 1.8 kilobase CBG mRNA in the rat liver and
Southern analysis suggested the presence of a single gene
for CBG. Similarly, Seralini et al. (1990) demonstrated that
the cDNA-deduced primary structure of rabbit CBG contains
383 amino acids( molecular weight = 42,326), including three

cysteine residues and four sites for N-glycosylation. It is
primarily the product of a 1.68-kilobase hepatic mRNA.
Kattesh and Roberts (1993) isolated and purified

porcine CBG from serum using affinity chromatography and
HPLC-DEAE anion exchange techniques. SDS-PAGE analysis of

porcine CBG revealed that the protein consists of two

polypeptides of approximately 54 and 59 kDa and both having
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significant amino acid homology (>50%) to that of rabbit ,
human and hamster CBG for the first 38 amino acids.

When human CBG was compared with other known protein

sequences, there was an unexpected finding that the protein
is structurally related with several members of the serine

protease inhibitor (SERPIN) superfamily (Hammond et al.,
1987). It has been demonstrated that neutrophil elastase

cleaves the CBG molecule in a position that is closely

aligned with the proposed elastase binding site on alphal-

proteinase inhibitor (Al-PI) resulting in a dramatic
reduction in CBG steroid binding activity (Pemberton et al.,
1988).

Biosynthesis of CBG

The liver has been identified as the major site of CBG

biosynthesis in guinea pig (Perrot-Applanat et al., 1981),
human (Khan et al., 1984), rat (Smith and Hammond, 1989),
rabbit (Seralini et al., 1990), hamster (Lin et al., 1990),

fetal sheep (Jacobs et al., 1991), and mouse (Scrocchi et
al., 1993). Elfahime et al.(1992) examined enriched

populations of hematopoietic

and parenchymatous cells

prepared from fetal liver for their abilities to accumulate
CBG mRNA and showed that the homogeneous hematopoietic cell

fraction (virtually free of hepatocytes) failed to
accumulate CBG mRNA while the parenchymatous cell fraction

did express the CBG gene. Also, CBG has been successfully
9

produced and secreted by hepatocytes in culture (Khan et
al., 1984; Rosner et al., 1984).

The nature of CBG-producing cells was studied in

guinea-pig liver by immunocytochemistry. CBG-stained
hepatocytes were more numerous in the peripheral regions of
the lobules and around the portal space. The rough

endoplasmic reticulum was identified as the site of CBG

synthesis in the guinea-pig hepatocytes (Perrot-Applanat et
al., 1981). Khan et al.(1984) demonstrated that a human

hepatoma cell line synthesized and secreted a protein that
was functionally, as well as physically and immunologically,
the same as CBG.

The transcription unit responsible for CBG mRNA in the
human liver has been characterized revealing the presence of

a highly conserved promoter region (Underbill and Hammond,
1989). The CBG gene promoter contains a consensus binding

sequence for the hepatocyte-specific transcription factor,
HNF-1. This factor is probably important in the development
of the liver phenotype and therefore is an essential part of

the transcriptional apparatus responsible for the expression
of the CBG gene in the liver (Hammond et al., 1991).
The availability of species-specific cDNAs for CBG
allowed for the detection of CBG mRNA by Northern blot

analysis of spleen and ovary RNA from adult rabbits
(Seralini et al., 1990) and kidney and pituitary RNA from

fetal sheep (Berdusco et al., 1995). The levels of CBG mRNA
10

in these tissues are relatively low when compared to adult

liver samples and, therefore, only a small proportion of
cells within these extra-hepatic tissues may express the CBG

gene (Seralini et al., 1990).

Roles of CBG in circulation

The generally accepted model of steroid hormone action
suggests that unbound steroid diffuses passively through
target cell membranes and binds to a soluble intracellular
receptor. The steroid-receptor complex apparently moves into
the nucleus where it modifies the chromatin transcriptional

activity which results in altered levels of protein
synthesis (Siiteri et al., 1982). A variety of extracelluar
binding proteins enhance the solubility of steroid hormones
in biological fluids and facilitate their transport from

steroidogenic tissues to target cells (Hammond, 1990). CBG

binds glucocorticoids with remarkably high affinity and
specificity. As a result, CBG not only transports

glucocorticoids but also modulates their bioavailability
(Siiteri et al., 1982) and may participate directly in the

delivery of steroids to certain cells by interaction with
plasma membrane receptors (Rosner, 1990).
The role that CBG serves in regulating the

bioavailability of cortisol can be demonstrated in the human

during pregnancy. Although the cortisol level rises
considerably during pregnancy, the percentage of cortisol
11

distributed among CBG, albumin and the unbound compartments

remains almost constant throughout pregnancy and is very
similar to those in normal women (Rosenthal et al., 1969).

It appears that the concomitant rise of CBG during pregnancy
keeps the physiologically available cortisol level low
enough so as not to produce Gushing's syndrome.
CBG serves primarily as a relatively inert reservoir
in which corticoids are protected from metabolism and

excretion, but still available by dissociation to provide
sufficient hormone when steroid production is increased

(Ballard, 1979). Lepper et al.(1988) demonstrated that the
increase in plasma corticosterone concentration in the rat

during the third week of life resulted from a decrease in
metabolic clearance rate(MCR) for corticosterone. The

decrease in MCR was due to a decline in the apparent volume

of distribution for corticosterone in plasma which is

affected through the increasing concentration of CBG because

of high affinity of CBG for corticosterone. On the other
hand, the authors also showed that the half-life of bound
corticosterone was less than that of free corticosterone and

suggested that bound corticosterone may be preferentially
metabolized by a mechanism for the internalization of CBG

through receptor-mediated endocytosis in the target tissues.
Specific binding sites for CBG were detected on membranes
perpared from rat spleen (Singer et al., 1988).

12

It has been known that CBG responds as an acute phase

negative protein dramatically decreased in serum during
inflammation and that serum CBG levels drop rapidly during

artificially induced inflammation (Savu et al., 1980).
During inflammation, activation of the neutrophils results
in the production of large amounts of superoxide radicals
and serine proteinases, specifically elastase (Hammond et
al., 1991). The production of superoxide radicals destroy

the ability of alphal-proteinase inhibitor(Al-PI) to inhibit
elastase and thereby allows this serine proteinase to
function more efficiently in a local context. On the other
hand, CBG is not influenced by the superoxide radicals and

retains its ability to interact with neutrophil elastase,
which is associated with the surface of these cells once

they have been activated (Hammond et al., 1991). The CBG is
then rapidly cleaved by elastase and provides a mechanism
for the delivery of relatively large amounts of

glucocorticoids to the activated neutrophils (Hammond et
al., 1990). At this stage in the inflammatory reaction, the

glucocorticoids down-regulate neutrophil activity by

decreasing the production of chemostatic factors (Fauci,
1979).

Since it has been suggested that serine proteinases

play an important role in the normal process of tissue
remodeling and development, it is possible that CBG may

promote the delivery of glucocorticoids to sites where rapid
13

growth and tissue remodeling are occurring as a result of
normal development (Hammond et al., 1991).

Factors affecting CBG production

The fetal rat has a relatively high concentration of

CBG until approximately 4 days before birth. At this time
circulating CBG levels begin to fall and rapidly reach low
values that are maintained through the first 9 days after
birth. During the second postnatal week, serum CBG

concentrations begin to rise again. This increase continues
until a plateau is reached on approximately day 24 (Henning,
1978; D'Agostino and Henning, 1981). Smith and Hammond
(1991) compared the levels of serum CBG and hepatic CBG mRNA
from day 15 of gestation

until 12 weeks of age after birth.

The hepatic CBG mRNA concentration in day 15 fetuses was

55.1 pg CBG mRNA/ug RNA and decreased progressively to 1.4

pg CBG mRNA/ug RNA by day 21 of gestation. At 1 week of age
after birth, the level of CBG mRNA was 0.4-0.8 pg CBG

mRNA/ug RNA and increased at least 5-fold by 2 weeks of age
after birth. After this time, CBG mRNA values doubled

reaching adult levels by 3 weeks of age. Although adult CBG
mRNA levels were attained by 3 weeks of age, serum CBG
concentrations did not reach adult values for an additional

3 weeks. Also, the half-life of CBG in infants (6.9 hours)

was consistently less than that in adults(14.5 hours). The
authors suggested that variations in CBG biosynthesis and
14

clearance may influence glucocorticoid action during fetal

and postnatal development (Smith and Hammond, 1991).
Gender differences in the circulating concentration of
CBG have been noted. Serum CBG level in the adult female rat

were 2.5 fold higher than that in the male( Jansson et al.,
1989; Mataradez et al., 1992). Likewise, hepatic CBG mRNA
content in the adult female was 3-fold higher than that of
the adult male (Smith and Hammond, 1989). This sexual

dimorphism in CBG gene expression may be attributed to sex
differentiation of growth hormone secretion induced by the
secretion of androgens and estrogen, but also by androgen

imprinting of the neonatal male rats (Jansson et al., 1984;
Jansson et al., 1989).

Measurement of CBG binding capacity is an indirect
method for measurement of CBG in plasma, based upon its

ability to bind radioactive cortisol (Siiteri et al., 1982).
Both age and sex-related changes in the binding capacity of
CBG for cortisol occur in the guinea pig during development

which parallel the changes in plasma cortisol concentration
(Dalle et al., 1980). CBG binding capacity for cortisol in

plasma was highest at birth (male: 2.15 umol/1; female: 2.20
umol/1) followed by a consistent and significant decrease by

day 10. On day 20, CBG binding capacity in the male(0.74
umol/1) was not different from that measured on day 10.

However, female guinea-pigs measured on day 20 had

significantly higher CBG binding capacity(1.6 umol/1) than
15

that found on day 10 (0.7 umol/1), which was significantly
higher than that of male animals at the same age.
Kattesh and Roberts (1993) documented the changes in

plasma CBG concentrations in the pig measured at various
ages from 3 to 126 days of age using enzyme-linked
immunosorbent assay (ELISA) procedures. The CBG

concentration decreased from day 3 (227.2 ug protein/1) to
day 7 (195.6 ug protein/1). The concentration of CBG was

significantly higher on day 28 (271.6 ug protein/1) reaching
a plateau on day 42 (351.4 ug protein/1). The increase in
CBG levels around 28 days of age reflect corresponding

changes in the percent distribution of cortisol among
protein bound and free forms in the pig as documented
earlier (Kattesh et al., 1990).
Hsu and Kuhn(1988) demonstrated a diurnal variation in
the level of CBG similar with that in cortisol, with the

highest levels detected at the beginning of the dark or

active period in the rat. The circadian variation in serum
CBG was the result of changes in the distribution of CBG

between plasma and interstitial fluid, and the relative
distribution of CBG is determined by permeability of the

capillaries to CBG which is decreased by corticosteroid
(Ottenweller et al., 1979).

Species-specific variations in CBG concentration have
been noted in the gestating female. In the women (Rosenthal
et al., 1969), rabbit (Seralini et al., 1990) and hamster
16

(Lin et al., 1990), plasma CBG is considerably elevated

during pregnancy.

In the pregnant rat, CBG levels remain

almost unaltered(Smith and Hammond, 1989). In contrast, the

mare shows a significant decrease in CBG binding capacity in

plasma throughout pregnancy and this decrease may be due to
an increase in CBG uptalce by the tissues (Martin and
Silberzahn, 1990).

Hormonal regulation of CBG production

Many studies have demonstrated that various hormones
are involved in the regulation of circulating concentrations
of CBG. The responses of CBG to these hormones may vary with
age.

During postnatal development in the rat, serum
concentrations of corticosterone begin to rise in parallel

with serum CBG levels (Kenning, 1978), but corticosterone

apparently has no effect on this developmental rise of CBG
(D'Agostino and Kenning, 1982). In the adult male rat,
dexamethasone (25 ug/lOOg body weight) injection for 2 days
decreased CBG production rate by liver slices in culture
(Feldman et al., 1979) and serum CBG and hepatic CBG mRNA
levels were also decreased after twice daily dexamethasone

(25 ug/lOOg body weight) injection for 3 days (Smith and
Hammond, 1992). Fetal sheep infused with the synthetic

glucocorticoid dexamethasone had increased plasma CBG
levels, hepatic CBG mRNA and the CoA binding forms, and
17

adult sheep treated with dexamethasone showed a significant
decrease in plasma CBG levels and hepatic CBG mRNA (Berduscc
et al., 1993). Gluccccrticcid treatment exerted opposite
effects on CBG biosynthesis in fetal and adult sheep. The
authors concluded that the response of the CBG gene to

glucocorticoid may be developmentally regulated.

Thyroxine(T4) exhibits developmental profiles similar
to CBG and its administration results in a precocious rise

in serum CBG during postnatal development (D'Agostino and

Henning, 1981, 1982). In the adult rat, T4 administration

twice daily for 3 days increased serum CBG and hepatic CBG
mRNA by 66% and 39%, respectively, but did not influences
the rate of CBG gene transcription. Thus, the elevated

hepatic CBG mRNA in these rats are probably mediated by
increased CBG mRNA stability (Smith and Hammond, 1992). The

magnitude of the T4 effect on CBG binding capacity during
the neonatal period is considerably greater than that seen
in adult rats (D'Agostino and Henning, 1981). Daily
administration of T4 to adults males for 7 days resulted in
a two fold elevation of CBG. In contrast, neonatal rats

subjected to a 7-day period of hyperthyroidism caused a 24fold increase in CBG concentrations. D'Agostino and

Henning(1982) demonstrated that the response of CBG to T4
increased with advancing age during development. Elfahime et
al.(1992) examined the effects of both T3 and rT3 on CBG
mRNA in liver from neonatal rats and showed that only T3 was
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able to enhance the level of the messenger. This suggests

that in the fetus, in which rT3 is the predominant form of

circulating thyroid hormone, liver CBG mRNA may be regulated
differently in neonates compared to adults.

Estrogen also shows developmental profiles similar to
CBG and is known to be involved in the regulation of adult
CBG concentrations. The administration of estrogens to

nonpregnant women resulted in a significant rise in CBG
concentration similar to that in noninjected pregnant women

(Slaunwhite and Sandberg, 1959). The adult male rat injected

y/ith estrogen showed a 100% increase in CBG secretion by the

perfused liver system (Fieldman et al., 1979). However, in
the postnatal rat, the developmental rise in the binding

capacity of CBG for cortisol in plasma is independent of
estradiol and estrone. This lack of response to estrogen

could be due to an insufficient number of receptors for

estrogen or lack of interaction of estrogen with the

hypothalamus because of secondary effect of estrogen on the
increase of thyroxine production through thyroid-stimulating
hormone (D'Agostino and Kenning, 1981).

Progesterone injection (25 ug/lOOg body weight for 3

days) to adult male rats did not alter serum CBG levels
(Smith and Hammond, 1992), but much higher doses(~5 mg/lOOg

body weight for 10 days) increased CBG levels in male rats

by 90% (Gala and Westphal, 1965). This may be indirectly
related to a reduction in circulating corticosterone levels
19

because the markedly elevated progesterone levels play some

part in displacing cortisol from CBG as part of the
competition for binding sites on CBG (Rosenthal et al.,
1969) and, therefore, much higher doses probably mimic the

postadrenalectomy rise in serum CBG levels (Smith and
Hammond, 1992).
Castration of mature rats led to a 40-50% increase in

CBG content and testosterone treatment led to a decrease by

40-50 % compared with vehicle-treated rats. However, the CBG
levels in immature castrated rats treated with testosterone

did not differ from that in vehicle-treated rats ( Mataradze

et al., 1992). Jansson et al.(1989) demonstrated that

neither androgen nor estrogen treatment affected the serum

CBG levels in hypophysectomized rats. However, continuous
infusions of growth hormone increased serum CBG levels in

both hypophysectomized male and female rats. They suggested
that the sex differentiation of growth hormone pulsatility

induced by testicular androgens and ovarian estrogens in the
adult rat mediate the effect of gender and gonadal steroids
on the sex difference in serum CBG levels of normal rats.
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CHAPTER III

MATERIALS AND METHODS

Animals

Twenty crossbred female pigs (Landrace, Duroc and

Hampshire breeding), born naturally and reared

conventionally, were used. Pigs were left with the sow (n=7)
in a conventional farrowing crate throughout the experiment.

All pigs were provided an 18% crude protein-pelleted creep
feed beginning on day 14 of age and water was provided ad
libitum. Four pigs each was randomly allotted for study on

days 3, 10, 20, 30, and 40 following birth.

Plasma collection and Tissue cultures

At the prescribed age a single pig was removed from
its litter, anesthetized by intramuscular injection of a

ketamine (15 mg/kg body weight) and acepromazine (0.5 mg/kg
body weight) solution. The animal was placed under general
anesthesia by closed circuit halothane administered by a gas
inhalation machine.

For determining plasma CBG level at each age studied,

a 4 ml blood sample was collected from the anterior vena
cava of each anesthetized pig and the sample placed in a

heparinized tube. Plasma was collected by centrifugation at
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3,000 rpm for 10 minutes at 4°C and stored at -20°C for
later CBG analysis.
Two lobes of liver were quickly removed from the

anesthetized pig and perfused with ice cold phosphate buffer

saline (PBS) solution (pH 7.4). Each lobe was sliced with a
double edged razor blade in cold HBSS solution (pH 7.4,

Sigma chemical Co., MO) and rinsed with cold HBSS solution.
Slices of uniform thickness (-0.5 mm) were blotted on

sterilized gauze and weighed. For each treatment

approximately 0.2 g of sliced liver were placed in dishes
containing 4 ml of Williams' medium E (pH 7.4, Gibco BRL,
NY) and pre-incubated in a humidified 5% CO2, 45% O2, and

50% N2 atmosphere at 37°C for 3 hours to remove blood from
the liver slices.

After pre-incubation, the samples were washed with
warm HBSS solution and 5 ml of treatment medium containing

the specific hormone concentration was added. Six samples of
each liver were incubated in triplicate in a humidified 5%

CO2, 45% O2, and 50% N2 atmosphere at 37°C. A 1 ml aliquot
of the culture media was collected after 12 hours incubation

and the remaining culture media was collected after 24 hours
incubation. The collected culture media was stored at -20°C
for the determination of CBG concentration.
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Hormone preparations
Hydroxycorticosterone, L-thyroxine, 17 beta-estradiol,

and progesterone (Sigma Chemical Co., MO) were initially

prepared in absolute ethanol. The working concentration of
hormone used was 10

_7

progesterone) and 10

_g

M (cortisol, thyroxine, and

M (estradiol) prepared in 0.5%

ethanol-media solution. The control group contained 0.5%

ethanol-media. An additional control group was made with

William's medium E alone.

Liver slices from each pig were

subjected to five treatments examined in triplicate.

Cell Viability

The leakage of lactate dehydrogenase (LDH) from liver
slices into medium during incubation was used as a reliable
indicator of cell viability in previous study (Smith et al.,

1985). LDH activity in liver slices or medium was measured
with a kit (catalog No.500, Sigma Chemical Co., MO; see

appendix A). The rate of cell death was expressed as the

percentage of cytoplasmic LDH activity leaked from liver
slices into medium compared to liver slices and medium

activity combined. LDH activity was measured at 12 and 24
hours of incubation for two pigs of each age.

Total protein measurement

The total protein released from liver slices during
incubation was measured with Coomassie Blue G-250 Reagent
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solution (Pierce Chemical Co., KC) by a micro coomassie
protein assay procedure (see appendix B). The amount of
total protein was expressed as microgram of protein released
per milligram of liver. Intraassay and interassay
coefficients of variation for 16 sets of triplicates from

serum pool of pig were 1.8 and 6.8%, respectively.

Enzyme-linked immunesorbent assay (ELISA) for CBG
The amount of CBG in plasma and synthesized by
cultured liver was measured by an ELISA for porcine CBG

(pCBG) developed by Kattesh and Roberts(1993) as outlined in
appendix C. Intraassay and interassay coefficients of
variation for 20 sets of duplicates from a serum pool of pig
plasma were 6.9% and 14%, respectively

Statistics

The results were analyzed using General Linear Mixed
Models (GLMM) procedures (Blouin and Saxton, 1990) in order
to determine differences in CBG concentrations with regard

to hormone treatment and age effect. Least square means and
standard errors were calculated for all variables.

Significant differences among means were partitioned using
Duncans procedures.
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CHAPTER IV

RESULTS

Body weight.

Mean (± SEM) pig body weight by age is

illustrated in figure 1. Body weight for each of the five

age groups increased (P<0.01) 10.5 kg in a linear fashion

from day 3 to day 40, with the greatest increase occurring
from days 30 to 40.

Cell death rate in liver slices during incubation.
Cell death rate was based on the percentage of cytoplasmic

enzyme lactate dehydrogenase (LDH) activity released from
liver slices into media after 12 and 24 hours incubation

compared to tissue and media activity combined. The
percentage of cell death following 12 hours of incubation
(44.9 + 6.1%; Figure 2) was approximately 19.4% less than

that following 24 hours of incubation (64.3 + 5.5%; Figure
3). The 12 hour cell death percentage in liver slices taken

from pigs on days 30 and 40 was 26.1 and 35.6%, respectively
which was lower (P<0.05) than that from pigs on days 3, 10,
and 20.

Total protein concentration in medium with and without
0.5% ethanol.

To determine whether ethanol affects the

release of total protein from liver slices during
incubation, an ethanol treatment group (0.5% final
concentration of ethanol in media) was compared to medium
25
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Figure 1. Body weight of pigs at each age studied. Each bar
represents the mean ± SE (n=4) . Columns with different
letters are significantly (P<0.01) different.
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Figure 2. The percentage of cell death in liver slice
cultures following 12 hours of incubation at each age
studied. Each bar represents the mean ± SE (n=2). Columns
with different letters are significantly (P<0.05) different
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Figure 3. The percentage of cell death in liver slice
cultures following 24 hours incubation at each age studied.
Each bar represents the mean ± SE (n=2).
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alone. There was no significant difference (P>0.10) between
the ethanol control group and medium alone (Figure 4).

Total protein concentration released from liver slices
during incubation.

Figure 5 shows the amount of total

protein released per unit weight of liver slices in medium
following 12 and 24 hour incubation for each age. The amount
of total protein released in medium was not different
(P>0.10) between time of incubation or age of pig studied.
Plasma CBG concentration.

The concentration of CBG in

plasma from pigs sampled on days 3 and 10 was lower (P<0.05)
than that measured on day 30 (Figure 6). CBG increased

(P<0.05) from 1.38 ± 0.06 ug/ml on day 10 to 2.18 ± 0.29

ug/ml on day 30.
CBG concentration from liver slices cultured in medium

alone by age.

Figures 7 and 8 show the concentration of

CBG released per unit weight of liver slices in medium
following 12 and 24 hour incubation, respectively. Culture
medium from liver slices incubated for 12 hours contained

less (P<0.05) CBG than those incubated for 24 hours (2.91 ±

0.39 ng/mg vs 3.91 ± 0.31 ng/mg, respectively). The
concentration of CBG released from liver slices following 12

hours incubation was higher (P<0.01) on day 10 than that

measured on the other days. The concentration of CBG
released from liver slices following 24 hours incubation did
not change from day 3 to day 40.

The percentage of CBG to total protein
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Figure 4. Total protein concentration from liver slices with
and without 0.5% ethanol following 24 hours incubation at
each age studied.
Total protein concentration is expressed
as microgram of total protein released per unit weight of
liver slice

(ug/mg) . Each bar represents the mean ± SE

(n=4) .
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Figure 5. Total protein concentration from liver slices
following 12 and 24 hours incubation in medium alone. Total
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protein released per unit weight of liver slice (ug/mg) .
Each bar represents the mean ± SE

31

(n=4) .

2.5

a

a b

b

1.5

•f-

O)

<5
m

o

0.5

Day 3

Day 10

Day 20

Day 30

Day 40

Age (day)

Figure 6. Plasma CBG concentration at each age studied. CBG
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plasma (ug/ml). Each bar represents the mean ± SE (n=4).
Columns with different letters are significantly (P<0.05)
different.
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Figure 7. CBG concentration from liver slices in medium
alone following 12 hours incubation. CBG concentration is
expressed as nanogram of CBG per unit weight of liver slice
(ng/mg). Each bar represents the mean ± SE (n=4). Columns
with different letters are significantly (P<0.01) different.
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Figure 8. CBG concentration from liver slices in medium
alone following 24 hours incubation. CBG concentration is
expressed as nanogram of CBG per unit weight of liver slice
(ng/mg). Each bar represents the mean ± SE (n=4).
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release of CBG relative to that of total protein, the
percentage of CBG to total protein was calculated for each
age studied. The overall percentage of CBG to total protein
following 24 hours incubation (0.042 + 0.006%; Figure 10) on
days 20, 30, and 40 was approximately two-fold higher than
those following 12 hours incubation (0.022 ± 0.002%; Figure

9). The percentage of CBG to total protein on day 10 (0.036
± 0.0023%) was higher (P<0.01) than that measured on days
20, 30, and 40 (0.026 ± 0.003%, 0.022 ± 0.005%, and 0.018 ±

0.004 %, respectively). This pattern was similar to that
seen for CBG release from liver slices following 12 hours
incubation.

CBG concentration from liver slices cultured in medium

with different hormones added.

There was no apparent

effect of hormone treatment on the release of CBG from liver

slices following 12 or 24 hours incubation (Figures 11 and

12). Thyroxine treatment on day 10 decreased (P<0.01) the
release of CBG from liver slices following 12 hour

incubation when compared to the other treatment groups of
the same age (Figure 11).
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Figure 9. The percentage of CBG to total protein released
from liver slices in medium alone following 12 hours
incubation. Each bar represents the mean ± SE (n=4). Columns
with different letters are significantly (P<0.01) different.
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from liver slices in medium alone following 24 hours
incubation. Each bar represents the mean ± SE (n=4).

37

b

3.5 -- T

C

-r

T b

4.5 -

=a

2.5 n

a
m

o

1.5

□ 0.5 % ethanol

■ Cortisol
S Progesterone
Bltiyroxine

0.5 --

0 Estradlol

Day 3

Day 10

Day 20

Day 30

Day 40

Age (day)
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CHAPTER V

DISCUSSION AND IMPLICATIONS

DISCUSSION

Cell death is classically evaluated by the

quantification of plasma membrane damage. The quantification
of plasma membrane damage is based on the measurement of

cytoplasmic enzyme activity released by the damaged cell.
Cytoplasmic enzyme leakage into the surrounding culture
medium provided a useful tool in the evaluation of

cytotoxicity (Dujovne et al., 1972; Acosta, et al., 1978).
In essence, this index of cytotoxicity assesses the

stability of the plasma membrane and its ability to retain

important intracellular enzymes (Anuford, et al., 1978).
Lactate dehydrogenase (LDH) is a stable cytoplasmic

enzyme in all cells. It is rapidly released into the cell
culture supernatant upon plasma membrane damage. The leakage
of LDH from the cells into the reaction medium was used

previously as an estimate of cellular damage (Medzihradsky
and Marks, 1975; Anuford, et al., 1978; Mitchell et al.,
1980). Medzihradsky and Marks (1975) showed that the pattern
of LDH release into the medium was markedly similar to that

of uptake of trypan blue and dead cell numbers. LDH leakage
was used as an indicator of parenchymal cell integrity in

preparing hepatic parenchymal cells from the livers of male
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rats (Brown and Bidlack, 1988). They showed that LDH leakage

from parenchymal cells increased with the decrease of trypan

blue dye exclusion following a 2 hour incubation.
Sawyer et al.(1994) used LDH leakage to assess cell

viability when examining the in vitro toxicity of ethanol
using the precision-cut rat liver slice. They showed that

exposure of liver slices to 0.5% ethanol had no effect on
cell viability regardless of the duration of exposure. Liver
slices exposed to 8% ethanol for 12 hours caused 35% loss of

cell viability. Results of the present study indicated
approximately 20 ~ 55% cell death following 12 hours of
incubation. The percentage of cell death on days 3, 10, and
20 were 20% higher than that on days 30 and 40. This high
rate of cell death during incubation may be due to variables

such as developmental maturity of liver or damage during the

preparation of liver slices. Also, there were no significant
differences in total protein or CBG in medium containing
0.5% ethanol compared to medium alone.

The total protein released from liver slices during
incubation was measured at each age to examine whether the

high cell death rate, incubation time or animal age affects

the protein synthesis of liver slices. The amount of total
protein released from liver slices showed little difference
between 12 and 24 hours incubation, regardless of age. The

percentage of cell death on days 30 and 40 significantly
decreased, but the amount of total protein released from
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liver slices remained unchanged. The release of total

protein from liver slices may not be influenced by
incubation time or animal age. However, the difference may
be masked by the large release of total protein due to
reduced cell viability, which is at least 20 % on day 30.
In several species it has been shown that serum or

plasma levels of CBG change two to four weeks after birth
(Kenning, 1978; Dalle et al., 1980; D'agostino and Kenning,
1981; Kattesh and Roberts, 1993). In the rat, plasma CBG

levels are very low during the first 9 days after birth and

significantly increase between days 9 and 12 until a plateau
is reached on day 24 (Kenning, 1978). In the female guinea

pig, CBG binding capacity for cortisol is high at birth,
significantly decreases by day 10 and then increases on day
20 (Dalle et al., 1980). Kattesh and Roberts (1993)

documented the changes in plasma CBG concentrations in the

pig measured from 3 to 126 days of age. The plasma CBG
concentration decreased from day 3 to day 7, but

significantly increased between 21 and 28 days of age. The

present study showed that plasma CBG levels were unchanged
by day 10, but increased 19% on day 20 and 33% on day 30
compared to day 10 values.
Liver has been identified as the major site of CBG

biosynthesis in the guinea pig (Perrot-Applanat et al.,
1981), human (Khan et al., 1984), rat (Smith and Hammond,

1989), rabbit (Seralini et al., 1990), hamster (Lin et al.,
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1990), fetal sheep (Jacobs et al., 1991), and mouse
(Scrocchi et al., 1993). Plasam CBG is primarily produced by
liver (Smith and Hammond, 1991; 1992).

The present study used the liver slice model because a
liver slice retains the normal microarchitecture so that

cell-cell communication is not disrupted (Smith et al.,
1985) and remains viable for 48 hours in culture using LDH

leakage and tetrazolium compound reductive capacity as
indicator of cell viability (Sawyer et al., 1994). Results

of the present study showed that the amount of CBG released

from pig liver slices during 12 hours incubation decreased

on day 30 in spite of a decrease in the rate of cell death,
while plasma CBG levels began to increase on day 20.
The liver slice model has been used in the rat to

examine the synthesis and secretion of CBG (Weiser et al.,
1979) and the hormonal regulation of hepatic CBG production
(Feldman et al., 1979; D'agostino and Kenning, 1982). CBG

production by liver slices increased linearly from 309 ± 32
fmol/mg of protein at 0 minute to 579 ± 86 fmol/mg protein
after 240 minutes in a time-dependent manner (Weiser et al.,
1979).

Generally liver consists of 60-65% parenchyma cells,
which are essentially hepatocytes, and 40% sinusoidal cells,
which consist of 44% endothelial, 33% Kupffer, 22%

lipocytes, and 1% pit cells (Berry et al., 1991; Phillips et
al., 1987). In the rat this percentage changes slightly with
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increasing liver weight and age from about 30% sinusoidal
cells at 200 mg of body weight to about 38% sinusoidal cells

at 440 mg of body weight (Aterman,1963).
In studies examining the localization of CBG

biosynthesis in the guinea pig liver, CBG was detected in
the cytoplasm of hepatocytes and was not detected in Kupffer
or bile duct cells (Perrot-Applanat et al., 1981). A

parencymatous-enriched cell population expressed CBG mRNA
while the homogenous hematopoietic cell population failed to
accumulate CBG mRNA (Elfahime et al., 1992). CBG secretion

by hepatocytes in culture has also been demonstrated (Khan
et al., 1984; Rosner et al., 1984).
Smith et al (1991) demonstrated that although adult rat

CBG mRNA levels were attained by 3 weeks of age, serum CBG
concentrations did not reach adult values for an additional

3 weeks, and that the half-life of CBG in 3 week old infants
(6.9 hours) was consistently less than that in adults (14.5
hours). Therefore, the age-related differences in the

clearance of CBG may be responsible for age-related

difference in secretary profiles of CBG from liver slices
and subsequent plasma CBG concentrations.

A positive relationship between liver weight and body
weight was reported in three different breeds of pigs by
Herpin et al. (1993). They showed that at birth, the
absolute weight of the liver in a Chinese breed of pig (23.6

g, liver weight; 814 g, body weight) was lower than that in
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a European breed (38.4 g, liver weight; 1,289 g, bodyweight) as well as a composite line highly selected for lean
tissue growth (34.3 g, liver weight; 1,451 g, body weight).
From the present data, although the release of CBG per unit
weight of liver tissue decreased, the amount of CBG released
from the entire liver may be increased by the increase of

liver weight associated with increasing body weight. This
may have contributed to the increase in plasma CBG levels.
Elfahime et al (1992) examined the difference between

plasma CBG levels and hepatic CBG mRNA contents in neonatal
rats. They showed that hepatic CBG mRNA levels and plasma
CBG concentrations increased in parallel from postnatal day
10 to day 15, but hepatic CBG mRNA levels decreased on day
20 while plasma CBG levels continued to increase. They
suggested that difference between plasma CBG levels and

hepatic CBG mRNA content may be due to an increase in CBG
half-life in circulation, which was about 3 days. This
observation was similar to the result of the present study

in that plasma CBG levels increased on day 30 while CBG
release from liver slices decreased on day 20.
Therefore, an increase in CBG half-life (Smith et al.,

1991), an increase in liver weight (Herpin et al., 1993) and

a decrease in hepatic CBG mRNA levels (Elfahime et al.,
1992) associated with increasing age may be responsible for

the age-related difference in the profiles of the release of
CBG per unit weight of liver tissue and plasma CBG
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concentrations in the present study. Furthermore, although
the amount of CBG released from liver slices following 12
hours incubation increased on day 20, the amount of total

protein remained unchanged over the ages studied. This
suggests that regulation in CBG release by liver may be
working independent from that in the release of other
proteins.

The hormonal regulation of the ontogenic rise in serum
CBG in the rat was investigated by D'agostino and Henning
(1981). They examined serum CBG binding capacity on day 8

after daily injections of estrogen or thyroxine on postnatal
days 2 through 7 and suggested that the developmental rise
in the binding capacity of CBG was independent of estradiol
and estrone and instead was elicited by the rising
concentrations of circulating thyroxine that normally occurs
in the early postnatal period. To examine the temporal

characteristics of the CBG response to thyroxine, D'agostino

and Henning(1982) gave n-propylthiouracil (PTU) -induced

hypothyroid rats a single injection of thyroxine (0.1 ug/g
body weight) on postnatal days 5, 6, or 7. They demonstrated
that only animals treated on day 7 showed a significant
increase in serum CBG levels and suggested that the response

of CBG to thyroxine was a function of the age of the animal.
Research by Feldman et al. (1979) examined hormonal

regulation of hepatic CBG production using liver slices from
adult male rats. They showed that glucocorticoid (25 ug/lOOg
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body weight) administration for 2 days reduced the rate of

CBG production and secretion and estradiol (15 ug/lOOg body
weight) stimulated the rate of CBG production. Their
experiment suggested that there is multihormonal regulation
of the rate of CBG synthesis by liver and these hormonal
treatments alter circulating CBG levels. Smith and Hammond
(1992) examined hepatic CBG mRNA levels in adult male rats

following twice daily administration of steroids or

thyroxine for 3 days. They showed that dexamethasone (25
ug/lOO g body weight) treatment decreased hepatic CBG mRNA

synthesis and thyroxine (10 ug/lOO g body weight)increased
CBG mRNA stability, while estradiol (25 ug/100 g body
weight), corticosterone (25 ug/lOO g body weight), and
progesterone (25 ug/100 g body weight) did not affect
hepatic CBG mRNA levels.
All of above results came by studies examining the
effects of in vivo hormone administration. In an in vitro

experiment, a human hepatic cell line exhibited increased
secretion of testosterone-estradiol-binding globulin (TeBG)
but not CBG after 48 hours in culture with physiological

concentrations (5 x 10"^ M) of thyroxine (Rosner et al.,
1984). Estradiol (5 x 10"^ M) treatment did not influence
the levels of TeBG or CBG . They concluded that the effect

of thyroxine is specific and the known effects of estradiol
in increasing plasma CBG are either indirect or function by

retarding the clearance of CBG from plasma. Likewise, the
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present data showed that there were no apparent effects of

in vitro hormone treatment on the release of CBG by liver
slices in the pig. These results suggest that the hepatic
secretion of CBG in the young pig is not influenced by
hormones of the kinds and amounts used in this study.

IMPLICATIONS

This study was conducted to investigate the

relationship between age and hormonal regulation of in vitro
hepatic secretion of corticosteroid-binding globulin in the
young pig. Plasma corticosteroid-binding globulin (CBG)

level was low by day 10 after birth and increased on day 30.
However, the release of CBG per unit weight of liver tissue

was high on day 10 and decreased on day 20. Although the
release of CBG per unit weight of liver tissue decreased on

day 20, the increase of plasma CBG on day 30 may be due to
the total increase of CBG released by the total liver and/or
an increase of CBG half-life with age. The amount of total
protein released per unit weight of liver tissue was not

changed with age. Therefore, the secretion of CBG by liver
tissue may be regulated in a different manner from that of

other proteins. The absence of a hormone treatment effect on
the release of CBG from liver tissue suggests that
regulation of CBG release from the liver may be related

primarily to age in the young pig.
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APPENDIX A
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PROCEDURE FOR CELL VIABILITY ASSAY

I. Preparation of reagents

A. 0.4 N NaOH solution

1.6 g NaOH anhydrous, 100 ml C02-free water.

1. Seal with paraffin film and mix gently.
2. Store at 4 °C.

B. Pyruvate/NADH substrate (Sigma Chemical Co., MO)
1 ml Pyruvate substrate , 1 vial NADH
1. Incubate for a few minutes in 37°C deionized

water bath just before use.

II. Preparation of samples

A. 0.2 g of sliced liver was incubated in 5 ml
Williams' Medium E or 5 ml Williams' Medium E

containing 0.5% ethanol.
B. The sample was incubated in a humidified 5% CO2, 5%
O2, and 90% N2 at 37°C for 12 or 24 hours.
C. 1 ml of the culture medium was taken off and stored

at -70°C for LDH activity assay.

D. The remaining medium containing liver slice was
homogenized with glass homogenizer and centrifuged
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for 10 minutes at 3,000x g with Beckman J2-HS
centrifuge (Beckman Instruments Inc., CA).

E. The supernatant was stored at -70 °C for LDH activityassay.

III. Measurement of LDH activity

A. Dilute 1 part of sample with 4 parts of Williams'
Medium E.

B. Put 10 ul of the sample in a microcentrifuge tube.

C. Add 100 ul of pyruvate/NADH substrate and gently
mix.

D. Incubate for exactly 30 minutes in 37°C water bath.
E. Add 100 ul of Color Reagent (Sigma Chemical Co., MO)
and mix well by swirling.
F. Allow to remain at room temperature for 20 minutes.
G. Add 1 ml of 0.4 N NaOH solution, cap and mix well by
inversion

H. Wait at least 5 minutes after adding 0.4 N NaOH
solution and transfer to cuvet.

I. Read an absorbance[A] at 442 nm on a Beckman DU 640

spectrophotometer (Beckman Instruments Inc., CA).

IV. Calibration curve for LDH assay
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A. Label 6 test tubes and prepare mixture at below.

Tubg Number

Pyruvate

Peionized

LDH activity

substrate

Water

(b-b unit/mi)

1

100 ul

10 ul

0

2

80 ul

30 ul

28

3

60 ul

50 ul

64

4

40 ul

70 ul

104

5

20 ul

90 ul

153

6

10 ul

100 ul

200

B. Add 100 ul of Color Reagent.

C. Mix gently and let sit at room temperature for 20
minutes.

D. Add 1 ml of 0.4 N NaOH solution.

E. Wait at least 5 minutes after adding 0.4 N NaOH
solution and transfer to cuvet.

F. Read the absorbance[A] on a Beckman DU 640

spectrophotometer.

G. Select a wavelength which will result in an

absorbance of approximately 0.9 for tube 1, using
water as reference.

H. Plot the absorbance[A] vs the corresponding LDH
unit.

V. Calculation
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A. Determine LDH activity of sample from calibration
curve.

B. LDH activity of each sample is recalculated to

Unit/mg of liver tissue.
C. Cell death rate is expressed as the percentage of

the activity of LDH released from liver slices into
medium compared to liver slices and medium activity
combined.
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PROCEDURE FOR PROTEIN QUANTIFICATION

I. Preparation of reagents

A. Dilution buffer

1.211 g Tris

1. Bring to 1,000 ml with deionized water
2. Adjust pH to 7.6
3. Store at 4°C

B. Bovine serum albumin (BSA) stock solution

1. Mix 40 ul of 2 mg/ml Pierce BSA (Pierce
Chemical Co., KC) with 360 ml Dilution buffer,

C. Standard solution
1. Standard concentrations are:

Standard

concentration

BSA stock

Dilught buffer

(200 ug/ml)

25 ug/ml
20 ug/ml
15 ug/ml
10 ug/ml
5 ug/ml
1 ug/ml

100 ul
80 ul
60 ul
40 ul
20 ul
4 ul

0 ug/ml

0 ul
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700
720
740
760
780
796

ul
ul
ul
ul
ul
ul

800 ul

II. Procedures

A. Dilute 1 part of sample with 39 parts of Diluent
buffer.

B. Mix Coomassie Blue G-250 Reagent with standards,
samples, or reference serum dilution (1/160) in a
1:1 ratio (vloume:volume) to a final volume of 640

ul in 12 X 75 mm glass tubes

C. Vortex immediately after adding reagent.
D. Load 200 ul of each mixture into the 96 well plate
(Corning, NY).
E. Read the plate at 595 nm on a BioTek Automated

Microplate Reader (Winooski, VT) between 5 and 60
minutes after adding reagent.

F. Calculate the results using Kineticalc software.

G. The amount of protein is expressed as microgram of
protein per milligram of liver tissue.
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PROCEDURE FOR ENZYME-LINKED IMMUNOSORBENT ASSAY

(ELISA)

I. Preparation of Reagents

A. lOx Phosphate buffered saline (PBS) solution
80 g NaCl, 12.07 g Na2HP04, 20 g KH2PO4,
2.0 g KCl, 2.0 g Sodium azide
1. Bring to near 1,000 ml with deionized water.

2. Adjust pH to 6.8.
3. Bring to 1,000 ml with deionized water.
4. Store

at 4°C.

B. 10% Bovine serum albumin (BSA) solution

25 g bovine serum albumin (Fisher Biotech, NJ),
25 ml lOx PBS

1. Bring to 250 ml with deionized water.
2. Stir until dissolved at 4°C.
3. Sterilize with 0.2 nm filter.
4. Store at 4°C.

C. lOx Tris-buffered saline (TBS) solution

350.64 g NaCl, 96.88 g Tris, 8.0 g Sodium azide
1. Bring to near 4,000 ml with deionized water.
2. Adjust pH to 7.4.

3. Bring to 4,000 ml with deionized water.
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4. Store at room temperature.

D. 10% Tween 20
50 ml Tween 20

1. Bring to 500 ml with deionized water.
2. Thoroughly rinse tween container to wash out
the total 50 ml
3. Store at 4°C.

E. Glassware treatment solution

10 ml 10% BSA, 90 ml lOx PBS

1. Bring to 1,000 ml with deionized water.
2. Store at 4°C.

F. Wash buffer

400 ml lOx TBS, 20 ml 10% Tween 20

1. Bring to 4,000 ml with deionized water.
2. Store at room temperature.

G. Ix Diluent solution

100 ml 10% BSA, 90 ml lOx PBS, 5 ml 10% Tween

20, 5 mg Bromophenol blue

1. Bring to 1,000 ml with deionized water.
2. Store at 4°C.

67

H. 2x Diluent solution

200 ml 10% BSA, 180 ml lOx PBS, 10 ml 10% Tween

20, 300 ml 0.2 N Heps
1. Bring to 1,000 ml with deionized water.
2. Adjust pH to 7.4.
3. Store at 4°C.

I. Tris coating buffer solution
2.4422 g Tris, 5.84 g NaCl, 0.2 g Sodium azide
1. Bring to 1,000 ml with deionized water.
2. Adjust pH to 8.5
3. Store at 4°C.

J. 5% Na2EDTA solution
25 g Na2EDTA

1. Bring to 500 ml with deionized water.
2. Store at 4°C.

K. Standard solution.

1. For standards porcine CBG from pig serum pool
was isolated and purified by affinity
chromatography and HPLC-DEAE anion exchange

technique and adjusted to 12.152 ng/ul by
dilution with Ix PBS.

2. Standard stock solution was prepared in bulk

and aliquoted with Williams' Medium E.
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3. Standard concentrations are:

ng/wgll

ng/ul

pCBg StOoK

Williams'

(ul)

Medium (ul)

2,632.88

7,367.17

160

3.2

50

1

822.77

9,177.23

20

0.4

329.11

9,670.89

8

0.16

131.64

9,868.36

2.5

0.05

41.14

9,958.86

1.0

0.02

16.46

9,983.54

0.3

0.006

4.94

9,995.06

L. CBG antibody stock solution

1. Rabbit anti-pCBG was from a rabbit injected
with CBG purified from porcine plasma.

2. A 1/1,000 dilution of antiserum was prepared
with Ix Diluent solution.

3. Store in 250 ul aliquots in screw cap vial and
frozen at -70°C.

M. CBG coating solution for 50 plates.

8,227.74 ul pCBG stock (12.154 ng/ul) solution,
491,772.26 ul Tris coating buffer.
1. Prepare immediately before use.

N. Substrate solution

1. For every 5 mis of substrate, mix 1 ml
diethanolamine buffer(5x), 4 ml deionized

water, and

1 tablet of p-nitrophenyl-phosphate
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(Kirkegard & Perry Lab., MD).
2. Agitate gently to dissolve the tablet
3. Prepare the buffer just before use.

II. Procedure

A. Coat plate (Corning 96 well ELISA plate, NY) with

purified porcine CBG (20 ng/well) by incubating at
4°C for 48 hours.

B. Concurrently, in a separate previously blocked
plate, incubate samples (40 ul/well), reference
porcine serum (5 ul/well), 2x Diluent control (50

ul/well) or standard porcine CBG (0.3 to 160

ng/well) with rabbit anti-pCBG serum at final
dilution of 1/500,000 at 4°C for 48 hours.

C. Wash the pCBG coated plate with wash buffer using a
Dynatech Ultrawash II Microplate Washer (Chantilly,
VA),8-4-1-4 cycle and tap dry on paper towels.
D. Transfer the sample-antibody mixture (100 ul/well)

to the corresponding wells of the coated plate and
incubate in a humidified chamber at 30°C for 2
hours.

E. Wash the plate using 8-4-1-4 cycle on the plate
washer and tap day.

F. Add 100 ul/well of anti-rabbit IgG alkaline
phosphatase conjugate (Sigma Chemical Co., MO) in a
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1/12,000 dilution with Ix Diluent and incubate in a
humidified chamber at 30°C for 2 hours.

G. Wash the plate using 8-4-1-4 cycle on the plate
washer and tap day.

H. Add the phosphate substrate (100 ul/well) and
incubate in a humidified chamber at 30°C for 1
hours.

I. Stop the reaction with an equal volume of 5% Na2EDTA
solution.

J. Read the plate at 405 nm on a BioTek Automated

Microplate Reader (Winooski, VT).
K. Calculate the amount of CBG in the sample using a
four parameter fit, kineticalc software (Bio-Tek
Instruments, Inc., VT).
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